An open, randomized pilot study to evaluate the use of basiliximab with an optimized cyclosporine dosing on renal function in de novo liver transplantation.

Trial Profile

An open, randomized pilot study to evaluate the use of basiliximab with an optimized cyclosporine dosing on renal function in de novo liver transplantation.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2010

At a glance

  • Drugs Basiliximab; Ciclosporin; Corticosteroids; Mycophenolate mofetil
  • Indications Liver transplant rejection
  • Focus Pharmacodynamics
  • Sponsors Novartis
  • Most Recent Events

    • 24 Aug 2010 Actual end date (April 2005) added as reported by ClinicalTrials.gov.
    • 24 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top